The current position： Home>Technology

Technology
- 干细胞
- 免疫细胞

Translational medicine
- 干细胞治疗
- 免疫细胞治疗

Academic center

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged ... [more]

Technology

Authoritativeness

We have built the CHINA CONTINUING MEDICAL STEM CELLS TRANSPLATION TECHNOLOGY CLINICAL APPLICATION. We have made important breakthrough in the stem cell application to the treatment of many kinds of disease.

上一篇：A New Milestone: US released the Phase II Stem Cell Clinical Trials

下一篇：Safety

Hepatology Hospital
China-Japan Union Hospital
The Second Hospital
Hospital Jilin Province
The Third Hospital
The First Hospital